Food pricing, competition, and the emerging supercenter format

Much previous research has examined the role of concentration, level of service, and entry barriers on U.S. food retailing profits and prices. Despite the rapid advancement of food supercenters, public policy research evaluating their price impacts remains quite limited. The purpose this study is to examine the price impacts from supercenter entry, growing supercenter market share, and supermarket consolidation from 1993-2003. Findings were that both the market share of supercenter food sales and the marginal impact of supercenter entry did not have a significant impact on food prices in the metropolitan statistical areas (MSAs) analyzed. These are important findings in light of claims that supercenters entry causes a procompetitive effect. Futhermore, changes in market concentration was significantly and positively related to price changes. Therefore, it appears consolidation led to higher prices and any merger-related cost gains during this period were not passed on to consumers. [EconLit Classifications: D400, L130, L660]. © 2007 Wiley Periodicals, Inc. Agribusiness 23: 295-312, 2007.

New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

The Consortium of Eosinophilic Gastrointestinal Diseases and the International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the recent 2018 Annual Meeting of the American Academy of Allergy, Asthma & Immunology, which was coupled for the first time with the World Allergy Organization meeting to create an international platform. The symposium featured experts in many facets of eosinophilic gastrointestinal diseases, including allergy, immunology, gastroenterology, pathology, and nutrition, and was a well-attended event. The basic science, genetics, cellular immunology, and clinical features of the diseases, with a focus on epithelial, eosinophil, and mast cell responses, as well as current and emerging treatment options, were reviewed. Here we briefly review some of the highlights of the material presented at the meeting

New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

The Consortium of Eosinophilic Gastrointestinal Diseases and the International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the recent 2018 Annual Meeting of the American Academy of Allergy, Asthma & Immunology, which was coupled for the first time with the World Allergy Organization meeting to create an international platform. The symposium featured experts in many facets of eosinophilic gastrointestinal diseases, including allergy, immunology, gastroenterology, pathology, and nutrition, and was a well-attended event. The basic science, genetics, cellular immunology, and clinical features of the diseases, with a focus on epithelial, eosinophil, and mast cell responses, as well as current and emerging treatment options, were reviewed. Here we briefly review some of the highlights of the material presented at the meeting